Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Equillium (NASDAQ: EQ) shares plummeted 38% from $1.38 to 86 cents Thursday after the company said collaboration partner Ono Pharmaceutical let lapse its option to acquire Equilliums rights to itolizumab, a monoclonal antibody targeting the CD6-ALCAM signaling pathway, which plays a key role in modulating effector T cells that drive numerous immuno-inflammatory diseases
This process consolidates similar lawsuits into one court to more effectively manage pretrial proceedings: MDL for Efficiency : The MDL for Ozempic injury lawsuits ensures that common legal questions are addressed uniformly, reducing the risk of inconsistent rulings across different jurisdictions
Join us live in San Diego for our DiabetesEd Training Program Brand new agenda for 2026
Many patients begin seeing results within weeks, with continued weight loss over several months
It's everywhere right now
US$ 25.76
US$ 27.44
US$ 23.48
